https://prabadinews.com/
  • October 7, 2026
  • Last Update July 17, 2026 9:28 pm
  • United States of America

Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)

Safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)

A safety clinical trial shows a possible increased risk of cancer with the weight-loss drug Belviq, Belviq XR. Consider the benefits and risks when deciding to prescribe or continue patients on the drug.

administrator

Related Articles